Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Giovarelli

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
Head & Neck|March 1, 1991
Interleukin-2 injected around tumor-draining lymph nodes in head and neck cancerG Cortesina, A De Stefani, E Galeazzi, et al.
Blood|September 1, 1985
Interleukin 2 (IL 2) and interferon-gamma production by T lymphocytes from patients with B-chronic lymphocytic leukemia: evidence that normally released IL 2 is absorbed by the neoplastic B cell populationR Foa, M Giovarelli, C Jemma, et al.
Journal of the National Cancer Institute|July 16, 1997
Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12F Cavallo, P Signorelli, M Giovarelli, et al.
Journal of Clinical Immunology|July 1, 1989
B cells from chronic lymphocytic leukemia (CLL) patients are strong inducers of proliferation and major histocompatibility complex (MHC)-unrestricted [natural killer (NK)-like] cytotoxicity in normal T-lymphocytesL Matera, R Foa, M Massaia, et al.
International Journal of Immunopathology and Pharmacology|May 13, 2005
IL-10 enhances CCL2 release and chemotaxis induced by CCL16 in human monocytesT Musso, P Cappello, S Stornello, et al.
Anticancer Research|November 1, 1992
Ly-6A/E gene is widely expressed among transformed nonhematopoietic cells. Autocrine modulation by interferonP L Lollini, L Landuzzi, G Nicoletti, et al.
British Journal of Cancer|September 1, 1992
Control of H-2 expression in transformed nonhaemopoietic cells by autocrine interferonP Nanni, L Landuzzi, G Nicoletti, et al.
The Journal of Pathology|April 21, 1999
Interaction between endothelial cells and the secreted cytokine drives the fate of an IL4- or an IL5-transduced tumourE Di Carlo, A Modesti, A Coletti, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|September 1, 1989
[Perilymphatic injection of interleukin-2 (IL-2) in recurrent squamous cell carcinoma of the head and neck]G Cortesina, A De Stefani, M Giovarelli, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 1, 1996
Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alphaP Musiani, A Allione, A Modica, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Head & Neck|March 1, 1991
Interleukin-2 injected around tumor-draining lymph nodes in head and neck cancerG Cortesina, A De Stefani, E Galeazzi, et al.
Blood|September 1, 1985
Interleukin 2 (IL 2) and interferon-gamma production by T lymphocytes from patients with B-chronic lymphocytic leukemia: evidence that normally released IL 2 is absorbed by the neoplastic B cell populationR Foa, M Giovarelli, C Jemma, et al.
Journal of the National Cancer Institute|July 16, 1997
Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12F Cavallo, P Signorelli, M Giovarelli, et al.
Journal of Clinical Immunology|July 1, 1989
B cells from chronic lymphocytic leukemia (CLL) patients are strong inducers of proliferation and major histocompatibility complex (MHC)-unrestricted [natural killer (NK)-like] cytotoxicity in normal T-lymphocytesL Matera, R Foa, M Massaia, et al.
International Journal of Immunopathology and Pharmacology|May 13, 2005
IL-10 enhances CCL2 release and chemotaxis induced by CCL16 in human monocytesT Musso, P Cappello, S Stornello, et al.
Anticancer Research|November 1, 1992
Ly-6A/E gene is widely expressed among transformed nonhematopoietic cells. Autocrine modulation by interferonP L Lollini, L Landuzzi, G Nicoletti, et al.
British Journal of Cancer|September 1, 1992
Control of H-2 expression in transformed nonhaemopoietic cells by autocrine interferonP Nanni, L Landuzzi, G Nicoletti, et al.
The Journal of Pathology|April 21, 1999
Interaction between endothelial cells and the secreted cytokine drives the fate of an IL4- or an IL5-transduced tumourE Di Carlo, A Modesti, A Coletti, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|September 1, 1989
[Perilymphatic injection of interleukin-2 (IL-2) in recurrent squamous cell carcinoma of the head and neck]G Cortesina, A De Stefani, M Giovarelli, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 1, 1996
Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alphaP Musiani, A Allione, A Modica, et al.
Pageof 12